Literature DB >> 10469843

The genetics of disorders with synuclein pathology and parkinsonism.

M Farrer1, K Gwinn-Hardy, M Hutton, J Hardy.   

Abstract

Despite being considered the archetypal non-genetic neurological disorder, genetic analysis of Parkinson's disease has shown that there are at least three genetic loci. Furthermore, these analyses have suggested that the phenotype of the pathogenic loci is wider than simple Parkinson's disease and may include Lewy body dementia and some forms of essential tremor. Identification of alpha-synuclein as the first of the loci involved in Parkinson's disease and the identification of this protein in pathological deposits in other disorders has led to the suggestion that it may share pathogenic mechanisms with multiple system atrophy, Alzheimer's disease and prion disease and that these mechanisms are related to a synuclein pathway to cell death. Finally, genetic analysis of the synuclein diseases and the tau diseases may indicate that this synuclein pathway is an alternative to the tau pathway to cell death.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469843     DOI: 10.1093/hmg/8.10.1901

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  9 in total

1.  Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice.

Authors:  Amanda N Sacino; Mieu Brooks; Michael A Thomas; Alex B McKinney; Nicholas H McGarvey; Nicola J Rutherford; Carolina Ceballos-Diaz; Janice Robertson; Todd E Golde; Benoit I Giasson
Journal:  Acta Neuropathol       Date:  2014-05       Impact factor: 17.088

Review 2.  Review: Novel treatment strategies targeting alpha-synuclein in multiple system atrophy as a model of synucleinopathy.

Authors:  E Valera; G Monzio Compagnoni; E Masliah
Journal:  Neuropathol Appl Neurobiol       Date:  2016-02       Impact factor: 8.090

Review 3.  The neuropathology of multiple system atrophy and its therapeutic implications.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Auton Neurosci       Date:  2017-11-10       Impact factor: 3.145

4.  Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy.

Authors:  Elvira Valera; Kiren Ubhi; Michael Mante; Edward Rockenstein; Eliezer Masliah
Journal:  Glia       Date:  2013-12-06       Impact factor: 7.452

Review 5.  Presenile dementia syndromes: an update on taxonomy and diagnosis.

Authors:  M D Greicius; M D Geschwind; B L Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

Review 6.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

7.  Global microRNA expression profiling of Caenorhabditis elegans Parkinson's disease models.

Authors:  Suvi Asikainen; Martina Rudgalvyte; Liisa Heikkinen; Kristiina Louhiranta; Merja Lakso; Garry Wong; Richard Nass
Journal:  J Mol Neurosci       Date:  2010-01-21       Impact factor: 3.444

8.  Analysis of (CAG)n expansion in ATXN1, ATXN2 and ATXN3 in Chinese patients with multiple system atrophy.

Authors:  X Zhou; C Wang; D Ding; Z Chen; Y Peng; H Peng; X Hou; P Wang; X Hou; W Ye; T Li; H Yang; R Qiu; K Xia; J Sequeiros; B Tang; H Jiang
Journal:  Sci Rep       Date:  2018-03-01       Impact factor: 4.379

9.  SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans.

Authors:  Chris R Guthrie; Gerard D Schellenberg; Brian C Kraemer
Journal:  Hum Mol Genet       Date:  2009-03-09       Impact factor: 5.121

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.